The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
RYANAIR HLDGS PLC | SPONSORED ADS | 783513203 | 62,721 | 944,892 | SH | SOLE | 0 | 304,392 | 0 | 640,500 | |
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 245,269 | 1,847,462 | SH | SOLE | 0 | 1,211,526 | 0 | 635,936 | |
TAKEDA PHARMACEUTICAL CO LT | SPONSORED ADS | 874060205 | 154,650 | 8,991,290 | SH | SOLE | 0 | 5,954,076 | 0 | 3,037,214 |